- Home
- NPFD vs PRME Comparison
NPFD vs PRME Comparison
Compare NPFD & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPFD
- PRME
- Stock Information
- Founded
- NPFD 2021
- PRME 2019
- Country
- NPFD United States
- PRME United States
- Employees
- NPFD N/A
- PRME N/A
- Industry
- NPFD Trusts Except Educational Religious and Charitable
- PRME Medicinal Chemicals and Botanical Products
- Sector
- NPFD Finance
- PRME Health Care
- Exchange
- NPFD Nasdaq
- PRME Nasdaq
- Market Cap
- NPFD 462.7M
- PRME 191.7M
- IPO Year
- NPFD N/A
- PRME 2022
- Fundamental
- Price
- NPFD $19.35
- PRME $3.15
- Analyst Decision
- NPFD
- PRME Buy
- Analyst Count
- NPFD 0
- PRME 6
- Target Price
- NPFD N/A
- PRME $9.38
- AVG Volume (30 Days)
- NPFD 64.7K
- PRME 3.6M
- Earning Date
- NPFD 01-01-0001
- PRME 08-04-2025
- Dividend Yield
- NPFD 6.28%
- PRME N/A
- EPS Growth
- NPFD N/A
- PRME N/A
- EPS
- NPFD N/A
- PRME N/A
- Revenue
- NPFD N/A
- PRME $3,846,000.00
- Revenue This Year
- NPFD N/A
- PRME $104.12
- Revenue Next Year
- NPFD N/A
- PRME $196.78
- P/E Ratio
- NPFD N/A
- PRME N/A
- Revenue Growth
- NPFD N/A
- PRME 550.76
- 52 Week Low
- NPFD $14.50
- PRME $1.11
- 52 Week High
- NPFD $18.07
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- NPFD 67.62
- PRME 80.66
- Support Level
- NPFD $19.17
- PRME $2.28
- Resistance Level
- NPFD $19.36
- PRME $3.34
- Average True Range (ATR)
- NPFD 0.19
- PRME 0.32
- MACD
- NPFD 0.03
- PRME 0.13
- Stochastic Oscillator
- NPFD 93.58
- PRME 95.36
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.